During the past decade, MC Comac Medical Ltd. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MC Comac Medical Ltd." #1 sponsor was "Chiesi Farmaceutici S.p.A." with 3 trials, followed by "Astellas Pharma Europe B.V." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Medivir" with 2 trials sponsored and "Aquilon Pharmaceuticals S.A." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MC Comac Medical Ltd." #1 collaborator was "Comac Medical" with 1 trials as a collaborator, "FibroGen" with 1 trials as a collaborator, "IQVIA RDS Ireland Ltd" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MC Comac Medical Ltd." are "Chronic Obstructive Pulmonary Disease" (2 trials), "Osteoarthritis, Knee" (2 trials), "Pharmacokinetics" (2 trials), "Chronic Kidney Disease" (1 trials) and "Contraception" (1 trials). Many other conditions were trialed in "MC Comac Medical Ltd." in a lesser frequency.

Most popular intervention types in "MC Comac Medical Ltd." are "Drug" (18 trials), "Other" (3 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "MIV-711" (2 trials), "15 mg E4 multiple-dose" (1 trials), "15 mg E4 single-dose" (1 trials) and "30 mg estetrol (E4)" (1 trials). Other intervention names were less common.

The vast majority of trials in "MC Comac Medical Ltd." are 16 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MC Comac Medical Ltd.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in MC Comac Medical Ltd., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MC Comac Medical Ltd., 15 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".